Allarity Historical Financial Ratios
| ALLR Stock | USD 1.13 0.06 5.61% |
Allarity Therapeutics is presently reporting on over 102 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 4.8 K, Invested Capital of 63.1 K or Average Payables of 0.0 will help investors to properly organize and evaluate Allarity Therapeutics financial condition quickly.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Allarity Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. About Allarity Financial Ratios Analysis
Allarity TherapeuticsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Allarity Therapeutics investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Allarity financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Allarity Therapeutics history.
Allarity Therapeutics Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Allarity Therapeutics stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Allarity Therapeutics sales, a figure that is much harder to manipulate than other Allarity Therapeutics multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Invested Capital
Invested capital represents the total cash investment that shareholders and debt holders have contributed to Allarity Therapeutics. There are two different methods for calculating Allarity Therapeutics invested capital: operating approach and financing approach. Understanding Allarity Therapeutics invested capital allows investors to calculate measures of performance such as return on invested capital or return on capital employed.Payables Turnover
A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.Most ratios from Allarity Therapeutics' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Allarity Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Allarity Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. To learn how to invest in Allarity Stock, please use our How to Invest in Allarity Therapeutics guide.At this time, Allarity Therapeutics' Debt To Equity is relatively stable compared to the past year. As of 04/28/2025, Average Receivables is likely to grow to about 193.7 K, though Book Value Per Share is likely to grow to (0).
| 2024 | 2025 (projected) | Interest Debt Per Share | 0.001039 | 9.87E-4 | Revenue Per Share | 27.8K | 29.2K |
Allarity Therapeutics fundamentals Correlations
Click cells to compare fundamentals
Allarity Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Allarity Therapeutics fundamentals Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Ptb Ratio | 1.28 | 3.51 | 1.48 | (239.3K) | (275.2K) | (261.4K) | |
| Book Value Per Share | 6.9M | 2.5M | 166.6K | (0.001382) | (0.001589) | (0.00151) | |
| Free Cash Flow Yield | (0.21) | (0.23) | (6.01) | (1.9E-5) | (2.2E-5) | (2.3E-5) | |
| Operating Cash Flow Per Share | (1.9M) | (2.0M) | (1.5M) | (0.006402) | (0.005762) | (0.00605) | |
| Pb Ratio | 1.28 | 3.51 | 1.48 | (239.3K) | (275.2K) | (261.4K) | |
| Free Cash Flow Per Share | (1.9M) | (2.0M) | (1.5M) | (0.006402) | (0.005762) | (0.00605) | |
| Roic | (0.22) | (0.92) | (5.26) | 16.83 | (2.27) | (2.16) | |
| Net Income Per Share | (1.3M) | (3.5M) | (1.4M) | (0.005978) | (0.00538) | (0.005649) | |
| Cash Per Share | 76.7K | 2.6M | 178.9K | 8.3E-5 | 7.5E-5 | 7.1E-5 | |
| Pocfratio | (4.73) | (4.38) | (0.17) | (51.6K) | (59.4K) | (56.4K) | |
| Interest Coverage | (40.65) | (53.22) | (154.54) | (36.0) | 41.72 | 43.8 | |
| Capex To Operating Cash Flow | (7.91E-4) | (4.14E-4) | (0.00107) | (0.0172) | (0.0155) | (0.0147) | |
| Pfcf Ratio | (4.73) | (4.38) | (0.17) | (51.6K) | (59.4K) | (56.4K) | |
| Income Quality | 1.43 | 0.56 | 1.05 | 1.07 | 0.71 | 1.16 | |
| Roe | (0.19) | (1.42) | (8.5) | 4.33 | (2.08) | (2.18) | |
| Ev To Operating Cash Flow | (4.93) | (3.16) | (0.27) | (51.6K) | 1.05 | 1.1 | |
| Pe Ratio | (6.76) | (2.48) | (0.17) | (55.3K) | (49.8K) | (52.3K) | |
| Return On Tangible Assets | (1.74) | (1.24) | (3.21) | (5.98) | (1.08) | (1.14) | |
| Ev To Free Cash Flow | (4.93) | (3.16) | (0.27) | (51.6K) | 1.03 | 1.08 | |
| Intangibles To Total Assets | 0.91 | 0.57 | 0.66 | 0.83 | 0.75 | 0.58 | |
| Net Debt To E B I T D A | (0.25) | 0.71 | (0.099) | (0.0939) | 0.67 | 0.63 | |
| Current Ratio | 0.71 | 0.31 | 1.02 | 0.44 | 2.06 | 1.74 | |
| Tangible Book Value Per Share | (936.5K) | (1.2M) | (675.3K) | (0.00634) | (0.005706) | (0.005992) | |
| Shareholders Equity Per Share | 6.9M | 2.5M | 166.6K | (0.001382) | (0.001589) | (0.00151) | |
| Debt To Equity | 0.0666 | 0.0578 | 1.98 | (0.47) | 0.11 | 0.18 | |
| Graham Net Net | (1.4M) | (1.4M) | (879.2K) | (0.006901) | (0.006211) | (0.006521) | |
| Interest Debt Per Share | 518.2K | 209.4K | 349.0K | 9.03E-4 | 0.001039 | 9.87E-4 | |
| Debt To Assets | 0.0535 | 0.0219 | 0.26 | 0.11 | 0.0596 | 0.0613 | |
| Enterprise Value Over E B I T D A | (5.95) | (1.83) | (0.26) | (54.5K) | 0.67 | 0.7 | |
| Earnings Yield | (0.15) | (0.4) | (5.74) | (1.8E-5) | (2.1E-5) | (2.2E-5) |
Pair Trading with Allarity Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Allarity Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allarity Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Allarity Stock
Moving against Allarity Stock
The ability to find closely correlated positions to Allarity Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Allarity Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Allarity Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Allarity Therapeutics to buy it.
The correlation of Allarity Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Allarity Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Allarity Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Allarity Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Allarity Stock Analysis
When running Allarity Therapeutics' price analysis, check to measure Allarity Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Allarity Therapeutics is operating at the current time. Most of Allarity Therapeutics' value examination focuses on studying past and present price action to predict the probability of Allarity Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Allarity Therapeutics' price. Additionally, you may evaluate how the addition of Allarity Therapeutics to your portfolios can decrease your overall portfolio volatility.